GINGER MCMILLAN-BUCHANAN, ACNP
Acute Care Nurse Practitioner in TUPELO, Mississippi. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
GINGER MCMILLAN-BUCHANAN, ACNP reported a CMS MIPS final score of 93.1001/100 — above the 83.1 national average — and filed 1,178 Medicare Part D claims in 2023.
- 93.1001/100
- MIPS score · +10 vs avg
- 1K
- Part D claims, 2023
- 93%
- generic prescribing
- $152.8
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
GINGER MCMILLAN-BUCHANAN, ACNP's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
93 Top 29% higher than 71% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about GINGER MCMILLAN-BUCHANAN, ACNP?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Mississippi
How Acute Care Nurse Practitioner compares to other specialties among Mississippi providers
Acute Care Nurse Practitioner share within Mississippi
Acute Care Nurse Practitioner is one of the more visible NUCC categories in Mississippi
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
GINGER MCMILLAN-BUCHANAN, ACNP's 2023 MIPS final score plotted against the Acute Care Nurse Practitioner national average
- MIPS Final Score
- 93.1001/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Acute Care Nurse Practitioner) — 93.1001/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Acute Care Nurse Practitioner US NPIs
93.1001/100 MIPS final score — 10.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Acute Care Nurse Practitioner. Quality dim: 83.0821.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
GINGER MCMILLAN-BUCHANAN, ACNP appears in the CMS NPPES registry as a Acute Care Nurse Practitioner provider holding ACNP credentials at 830 S GLOSTER ST, TUPELO, MS, 38801, with a listed phone of (662) 377-7170. NPI 1073068003 was issued on 08/19/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MCMILLAN-BUCHANAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,178 prescription claims written by this provider, covering 297 Medicare beneficiaries and totaling roughly $38K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 1.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.1001/100 for the 2023 performance year (Quality 83.0821), compared with the national average of 83.1.
Acute Care Nurse Practitioner is a mid-sized specialty nationwide, with 24,583 enrolled providers across 53 states and an average of 576 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1073068003 |
|---|---|
| Specialty | Acute Care Nurse Practitioner |
| Credentials | ACNP |
| Gender | Female |
| NPI Issued | 08/19/2016 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm GINGER MCMILLAN-BUCHANAN, ACNP's current license status, disciplinary history, and board certifications with the Mississippi State Board of Medical Licensure in Mississippi before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GINGER MCMILLAN-BUCHANAN, ACNP. Source: openpaymentsdata.cms.gov.
Total received
$153
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
7% brand-name claims vs 93% generic, on 1,178 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,630
- Total Day Supply
- 36,628
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $24K
- Generic Drug Cost
- $14K
- Opioid Claims
- 21 (1.8% rate)
- Antibiotic Claims
- 196
Patient Demographics
- Average Patient Age
- 67.1 years
- Avg HCC Risk Score
- 1.61
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 93, 65-74: 121, 75-84: 70, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What GINGER MCMILLAN-BUCHANAN, ACNP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisone
Prednisone
127 claims
- Azithromycin
Azithromycin
96 claims
- Fluticasone Propio…
Fluticasone Propionate
69 claims
- Famotidine
Famotidine
66 claims
- Albuterol Sulfate … 49
Albuterol Sulfate Hfa
49 claims
- Ondansetron Hcl 49
Ondansetron Hcl
49 claims
- Pantoprazole Sodium 40
Pantoprazole Sodium
40 claims
- Tizanidine Hcl 36
Tizanidine Hcl
36 claims
| Drug | Claims |
|---|---|
| Prednisone | 127 |
| Azithromycin | 96 |
| Fluticasone Propionate | 69 |
| Famotidine | 66 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 49 |
| Ondansetron Hcl | 49 |
| Pantoprazole Sodium | 40 |
| Tizanidine Hcl | 36 |
| Doxycycline Hyclate | 32 |
| Ciprofloxacin Hcl | 29 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Acute Care Nurse Practitioner Overview
How GINGER MCMILLAN-BUCHANAN, ACNP fits within the Acute Care Nurse Practitioner landscape nationally.
GINGER MCMILLAN-BUCHANAN, ACNP's 1,178 claims are above the specialty average of 576.
Nearby Acute Care Nurse Practitioner Providers in Mississippi
Other clinicians with the same primary specialty enrolled in Mississippi, drawn from the same CMS NPPES roster as MCMILLAN-BUCHANAN.
Compare Acute Care Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Mississippi
Frequently Asked Questions
What is GINGER MCMILLAN-BUCHANAN, ACNP's specialty? ▼
How much does GINGER MCMILLAN-BUCHANAN, ACNP prescribe under Medicare Part D? ▼
What is GINGER MCMILLAN-BUCHANAN, ACNP's Medicare quality score? ▼
Where is GINGER MCMILLAN-BUCHANAN, ACNP located? ▼
What is GINGER MCMILLAN-BUCHANAN, ACNP's NPI number? ▼
Does GINGER MCMILLAN-BUCHANAN, ACNP prescribe more brand-name or generic drugs? ▼
Does GINGER MCMILLAN-BUCHANAN, ACNP prescribe opioids? ▼
How many Acute Care Nurse Practitioner providers are there in the US? ▼
What drugs does GINGER MCMILLAN-BUCHANAN, ACNP prescribe most often? ▼
Does GINGER MCMILLAN-BUCHANAN, ACNP accept Medicare? ▼
How can I verify GINGER MCMILLAN-BUCHANAN, ACNP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology